Wed, February 16, 2022

Roanna Ruiz Maintained (XERS) at Buy with Decreased Target to $6 on, Feb 16th, 2022

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-decreased-target-to-6-on-feb-16th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Roanna Ruiz of SVB Leerink, Maintained "Xeris Biopharma Holdings, Inc." (XERS) at Buy with Decreased Target from $8 to $6 on, Feb 16th, 2022.

Roanna has made no other calls on XERS in the last 4 months.



There is 1 other peer that has a rating on XERS. Out of the 1 peers that are also analyzing XERS, 0 agree with Roanna's Rating of Hold.



This is the rating of the analyst that currently disagrees with Roanna


  • Oren Livnat of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $5.4 on, Friday, December 31st, 2021